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Since 1957 (1-4) antibodies against nuclear antigens and particularly against DNA have 
been  recognized  in  sera  from  patients  with  systemic  lupus  erythematosus.  Such 
autoantibodies have also  been found in sera from NZB  x  NZW F1 hybrid mice (5,  6), 
which spontaneously develop an autoimmune disease resembling human systemic lupus 
erythematosus (7,  8). The pathogenetic role of DNA and of antibodies directed against 
DNA (anti-DNA antibodies),  particularly in kidney injury,  has been suggested both in 
human (9) and in animal pathology (6). This hypothesis has been further s~lpported by the 
finding that NZB x  NZW F1 hybrid mice that had been previously rendered tolerant to 
denatured DNA failed to develop glomerulonephritis (10). 
The spontaneous development of anti-DNA autoantibodies is still poorly understood. 
The triggering of the immune response to DNA could result from antigenic stimulation by 
antigens containing DNA in a particularly immunogenic state. It is likely that in mice this 
response  is genetically controlled (11, 12). However,  it  is possible that this response is 
modulated by thymus-dependent lymphocytes or by modifications of the immune status 
of the host, possibly induced by exogenous agents such as viruses or bacteria. Therefore, 
the  spontaneous  development  of anti-DNA  antibodies  may  be  due  to  the  release  of 
immunogenic DNA in a  host naturally,  or rendered,  responsive to this type of antigen. 
Many clinical or experimental conditions involving bacterial (13) or viral infections (11, 
14,  15)  have  been  reported  to  favor  the  formation  of  antinuclear  antibodies.  Such 
antibodies have also been found in sera from animals immunized with killed  gram-nega- 
tive bacteria (16, 17). 
The purpose of the present study was to better define the mechanisms by which 
bacterial  infections or bacterial  products may favor the formation of anti-DNA 
antibodies.  Particular attention  was  given to the  study of the  role  of bacterial 
lipopolysaccharide  (LPS) 1 on  the  immune  response  to  DNA.  Indeed,  LPS 
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preparations  are  well known  to  have  several  effects on  the  immune  system.  In 
addition to its potent adjuvant effect on antibody formation (18), LPS was shown 
to  have  a  mitogenic  activity  on  B  lymphocytes  (19,  20).  Moreover,  it  was 
demonstrated  that in some instances LPS could favor the termination of a  state 
of unresponsiveness  due  to  tolerance  maintained  at T-cell level when  LPS  and 
antigen  were  injected  simultaneously  into  mice  with  responsive  B  cells  (21). 
Since it has been postulated that a  similar state of unresponsiveness would exist 
for  some  autoantigens  (22,  23),  one  may  wonder  whether  bacterial  LPS  would 
favor the  development of autoimmunity. 
In the  present  study,  it was demonstrated  that  the  injection of bacterial LPS 
into mice, without any injection of exogenous DNA,  could lead to the tbrmation 
of anti-DNA  antibodies.  Furthermore,  a  significant release of DNA was demon- 
strated  in circulating blood a  few hours after the injection of LPS.  Both of these 
effects  were  also  observed  after  injection  of  the  lipid  A  fraction  of  the  LPS 
molecule. 
Material  and  Methods 
Mice.  6-10-wk-old  mice were  used  throughout  the  study.  C3H,  C57BL/6,  DBA/2,  and  Balb/c 
female mice were purchased from Charles  River Breeding  Laboratories,  Inc.,  Elbeuf, France. NZB 
and NZW mice were originally  provided by Dr F. J. Dixon from the Scripps  Clinic and Research 
Foundation, La Jolla, Calif., and inbred  in our own animal house. All NZB x NZW FI hybrids  were 
obtained by NZB male × NZW female matings. Athymic Balb/c nude (nu/nu) female mice, athymic 
C57BL/6 nude (nu/nu)  male mice, and littermate mice which were heterozygote  for the mutant gene 
(nu/+)  were purchased  from the Laboratory Animals Breeding and Research  Center (GI. Bomholt- 
gart Ltd., Ry, Denmark}.  OF1 outbred female mice were purchased from IFFA CREDO (Centre de 
recherche et d'~levage des Oncins, St. Germain-sur-l'Arbresle, France).  Blood samples were collected 
by orbital sinus  puncture and the sera were stored  at  -20°C until used. 
Lipopolysaccharides.  Polysaccharide  B  of:  Salmonella  typhimurium  (lot  563628), Salmonella 
enteritidis  (lot 586088}, Escherichia  coli 0127:B8 (lot 582337), and E. coli 0111:B4 (lot 587687} were 
obtained from Difco Laboratories,  Detroit, Mich. LPS from the mutant strain E. coli 0111:B4, J5 (J5 
LPS)  and Salmonella  minnesota  Re 595  (Re 595 LPS)  and lipid A extracted from E. coli 0111:B4 
prepared as described  by Chiller et al. (24) were kindly provided  by David Morrison  (Scripps  Clinic 
and Research Foundation). All these LPS preparations were diluted to the desired  concentration in 
sterile saline and were injected intraperitoneally in a final volume of 0.2 ml. 
Immunization.  Calf thymus DNA type V was purchased  from  Sigma Chemical Co., St. Louis, 
Mo. Denatured DNA was prepared by heating native DNA (0.5 mg/ml in phosphate-buffered saline, 
pH 7.0) at 100°C for 10 min and by transferring directly to an ice bath.  Methylated bovine serum 
albumin was purchased from Calbiochem,  San Diego, Calif'. Incomplete Freund's adjuvant (IFA) was 
obtained  from  Difco  Laboratories.  Complexes  of denatured  DNA  and  methylated  bovine  serum 
albumin  (mBSA-DNA complexes)  were  made  by  adding drop  by  drop  methylated  bovine  serum 
albumin (10 mg/ml in distilled water) to an equal weight of DNA with constant stirring.  After 10 min 
an emulsion was made with an equal volume of IFA. These complexes were injected intraperitoneally 
(0.3 ml containing 75 ttg of DNA per mouse}. 
Separation  of Double-Stranded  from Single-Stranded  DNA.  The separation of double-stranded 
DNA (DS  DNA)  from  single-stranded DNA (SS DNA)  was performed  using  methylated albumin 
kieselguhr chromatography according  to Sueoka  and Cheng  (25). 1.5  ×  10-cm columns were run by 
stepwise elution with solutions of increasing  NaC1 molarity (0.1, 0.25, 0.50, 1.0) buffered with 0.05 M 
P0,, pH 6.7. The last buffer was 1 M NaCl, 1.5 M NH~OH. As reported by Tan and Natali (26), DS 
DNA was eluted with 0.5 M NaCl buffer, while SS DNA was eluted with 1 M NaC1, 1.5 M NH4OH 
buffer. 
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was done according to Wold et al.  (27),  by precipitation of globulin-bound radiolabeled DNA with 
50% saturated ammonium sulfate. DNA was labeled either externally with iodine-125 or internally 
with tritium. SS DNA was iodinated according to Commerford (28).  [lzSI]DNA had a specific activity 
of about 4  ×  105 cpm/ttg at 30% counting efficiency. [3H]DNA  was prepared from human fibroblast 
cells L~s2 grown in culture in presence of [3H]thymidine. DNA was isolated by Marmur's technique 
(29).  The  preparation  of  [3H]DNA  had  a  specific activity  of 3  ×  103  cpm/ttg at  33%  counting 
efficiency. Purified DS  [~H]DNA  was obtained by fractionation on methylated albumin kieselguhr 
column. SS  [3H]DNA  was obtained by heat denaturation. Titrations were done as follows: 0.1 ml of 
serum diluted 1/10 in borate buffer (pH 8.4,  ionic strength 0.1)  was heated at 56°C for 30 min, then 
mixed with 0.2 t~g of [SH]DNA  (DS  [SH]DNA or SS  [SH]DNA)  or 0.01 t~g of [I~SI]DNA in 0.1  ml of 
borate buffer. These mixtures were incubated overnight at 4°C;  then  1.8 ml of 55.55%  saturated 
ammonium  sulfate  was  added.  After  an  incubation  at  4°C  for  30  min,  the  precipitates were 
centrifuged at 1,000 g for 30 min, then washed once with 50% saturated ammonium sulfate. []2sI  ]DNA 
precipitated was directly counted in a gamma counter. [SH ]DNA precipitated was dissolved in 0.5 ml 
of heated (70°C) distilled water and transferred into 15 ml of Dioxan scintillation fluid for counting in 
a LS 250 Beckman liquid scintillation counter {Beckman Instruments, Inc., Fullerton, Calif.). The 
results  were  expressed as  a  percentage of radiolabeled DNA  precipitated and  compared to  the 
non-specific precipitation obtained with normal sera from the various strains of mice which were 
studied. Titration of anti-DNA antibodies was also done on  sera fractionated by gel filtration on 
Sephadex G 200.0.5 ml of pools of sera previously dialyzed for 24 h against borate buffer was applied 
to a Sephadex G 200 column and eluted with borate buffer. For titrations, 90 ttl of fraction sample was 
added to 10 #l of normal mouse serum. 
Detection of Other Antibodies.  Antibodies to S.  typhimurium  LPS  were titrated  by  passive 
hemagglutination as previously described (30).  Antibodies to autologous erythrocytes were detected 
by direct Coombs' test (31). 
Estimation of DNA Content in Serum Samples.  DNA content in serum samples was determined 
by inhibition of radioimmunoassay. 0.1 ml of serum presumed to contain DNA, diluted 1/10 in borate 
buffer and heated at 56°C for 30  min, was added to 0.1  ml of [~25I]DNA (0.01  ttg)  or to 0.1  ml of 
[SH]DNA  (0.2 ttg) diluted in the same buffer. To these mixtures was added 0.1 ml of serum from a 
lupus patient which contained anti-DNA antibodies directed against both SS DNA and DS DNA 
diluted 1/50 in borate buffer and heated at 56°C for 30 min. After an overnight incubation at 4°C, 2.7 
ml  of 55.55% saturated  ammonium sulfate were added and  the percentage of radiolabeled DNA 
precipitated was measured. In the absence of cold DNA, about 40-60%  specific precipitation was 
obtained.  A  standard  inhibition  curve  was  established  with  normal  mouse  serum  containing 
increasing amounts of cold calf thymus DNA. Cold DS DNA and cold SS DNA were found to give a 
similar inhibition of the precipitation of radiolabeled DNA. In this system, DNA added to normal 
mouse serum at a concentration of 1 tLg/ml could be detected with a good reproducibility. The amount 
of DNA present in tested serum samples was estimated by reference to the standard curve. In some 
experiments, fractions eluted from methylated albumin kieselguhr columns were tested for DNA 
content. In these cases, after an overnight dialysis of the fraction against borate buffer, 90 #l of these 
fractions were added to 10 ttl of normal mouse serum previously tested for the absence of detectable 
amounts  of DNA.  The  DNA  content was  then  measured  in  0.1  ml  as  described above.  When 
inhibition was observed, its specificity was controlled in each case by pretreatment of the tested 
samples with DNase. 0.1  ml of DNase  (Deoxyribonuclease 1,  2600/mg,  Worthington Biochemical 
Corp.,  Freehold,  N.  J.)  at  a  concentration of  0.4  mg/ml  in  Veronal  buffer,  pH  7.2,  (Tampon 
Veronal-magnesium-calcium, Institut Merieux, Marcy l'Etoile, Rhone, France) was added to 0.025 
ml of the sample. Then, after an incubation of 3 h at 37°C, 0.025 ml of 1 M EDTA and 0.1 ml of borate 
buffer were added. After heating the mixture at 56°C for 30 min, 0.1 ml was used for DNA estimation. 
In the control tubes, EDTA was added before DNase in order to prevent its enzymatic action. 
Results 
Induction of Anti-DNA Antibodies by LPS.  In the first group of experiments, 
the  effects  of  S.  typhimurium  LPS  were  studied  on  the  anti-DNA  response 
induced  by  mBSA-DNA  complexes  in  6-wk  old  NZB  ×  NZW  F~  hybrid  mice 1192  DNA  RELEASE  AND  ANTI-DNA ANTIBODIES INDUCED BY  LPS 
known to be good responders to DNA  (11).  Four groups of seven NZB x  NZW 
females  were  studied:  The  first  group  was  immunized  by  intraperitoneal 
injections of mBSA-DNA complexes in IFA (75 #g of DNA) on days 0, 7, and 14. 
The second group was immunized as the first group with mBSA-DNA complexes 
but was injected intraperitoneally 4 h later with S. typhimurium LPS (50 #g on 
day 0, 25 #g on days 7 and  14). As a control, a third group was injected with the 
same  amount  of LPS  but  without  any  mBSA-DNA,  and  a  fourth group with 
saline alone. The titers of serum anti-DNA antibodies, expressed in percent of 
[SH]DNA precipitated, were measured on days  13,  21,  28,  35,  and  55,  and  are 
represented in Fig. 1. It was found that the antibody response directed against SS 
DNA  elicited  by  immunization  with  mBSA-DNA  complexes in  IFA  was  not 
increased  by  additional  injections  of  LPS.  However,  a  significant  anti-DNA 
antibody response was induced by injections of LPS alone. Mice receiving saline 
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Fro.  1.  Anti-DNA antibody levels of young NZB  x  NZW F~ hybrid female mice immunized 
with mBSA-DNA complexes (O) or mBSA-DNA +  LPS  (B),  mice  injected  with LPS alone 
(O),  or  with  saline  alone  (A).  The  injections  were  done  on  days  0,  7,  and  14.  Anti-DNA 
antibody levels are expressed as the mean percentage of SS  [3H]DNA precipitated obtained in 
each group. Vertical  bars represent the limits of 1 SD. 
did not show any significant modification of DNA-binding capacity during that 
period. The kinetics of the anti-DNA antibody response observed in the groups 
immunized with mBSA-DNA complexes were different from those observed in 
the  group  injected  with  LPS  alone.  In  the  former groups,  levels of anti-DNA 
antibodies increased until  day 28  and then remained high,  while in the group 
receiving LPS  alone, the anti-DNA  levels increased similarly until  day 28 but 
slowly decreased afterwards. In a  similar experiment, a  group of mice received 
injections of IFA alone. There was no increase of DNA-binding capacity through 
day 21, but a  slight and transient increase was observed on days 28 and 35. 
In the second group of experiments, this induction of anti-DNA antibodies by 
injections of LPS alone was studied in six strains of mice. 6-wk old female NZB x 
NZW F~ hybrids, C57BL/6, C3H, Balb/c, NZW,  and DBA/2 mice were injected 
intraperitoneally with S. typhimurium LPS (50 tLg on day 0, 25 ttg on days 7 and 
14).  Individual serum samples were collected on days 0,  14,  28,  50,  and  70 for 
measuring DNA-binding capacity. The mean values obtained in each group are 
shown in Fig. 2.  One can see that five inbred strains of mice, as well as NZB  x GILBERT J.  FOURNIE,  PAUL H.  LAMBERT,  PETER  A.  MIESCHER  1193 
NZW hybrids,  responded to LPS by formation of anti-DNA  antibodies.  At the 
doses used in this experiment, some strain-dependent differences existed in the 
anti-DNA  response.  NZB  ×  NZW  and  C57BL/6  mice  showed  an  early  and 
relatively high  anti-DNA  response,  while Balb/c,  NZW,  and DBA/2  mice were 
relatively low responders.  C3H  mice showed  an  anti-DNA  response which was 
halfway between the two previous groups. The kinetics of the anti-DNA antibody 
production  in  all  the  groups  injected  with  LPS  were  similar.  DNA-binding 
capacity  of sera  reached  a  peak  on  day  28  and  then  decreased.  The  hemag- 
glutina~ing titers of antibodies to S. typhimurium LPS were measured on days 13 
and 35 in these groups of mice injected with LPS. It was found that the anti-LPS 
response was quite similar in all strains except DBA/2, which exhibited a  lower 
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FIG. 2.  Induction of anti-DNA antibodies in various strains of mice by injections of LPS. 50 
#g of S. typhimurium LPS was injected intraperitoneally on day 0, 25 #g on days 7 and 14. 
Anti-DNA antibody levels are expressed as the mean percentage of SS [SH]DNA  precipitated 
obtained in each strain. 
hemagglutinating titer. The Coombs' test, which was performed in NZB ×  NZW 
and C57BL/6 mice on days 13 and 28,  remained negative after the injections of 
LPS. In order to compare the anti-DNA response induced by injections of LPS 
with that induced by immunization with exogenous DNA, similar groups of the 
same  strains  of mice  were  immunized  with  mBSA-DNA  complexes  (75  tLg of 
DNA on days 0, 7, and 14). The levels of anti-DNA antibodies measured at day 28 
after stimulation either with LPS or with mBSA-DNA are shown in Table I. It is 
evident that NZB ×  NZW and C57BL/6 mice were good responders while DBA/2 
were  poor responders  to  both kinds  of stimuli.  However,  C3H  mice showed  a 
better anti-DNA response after injections of LPS than after immunization with 
mBSA-DNA.  Inversely,  NZW  mice  showed  a  better  anti-DNA  response  after 
immunization  with  mBSA-DNA  than  after  injection  of  LPS.  When  serum 
samples  obtained  later  (days  50  and  70)  were  analyzed,  it  appeared  that 
anti-DNA levels were still increasing in all strains except DBA/2 after injection of 
mBSA-DNA, while they were generally decreasing slowly in mice receiving LPS. 
In the third group of experiments, the effects of LPS were studied in athymic 1194  DNA RELEASE AND ANTI-DNA ANTIBODIES  INDUCED  BY LPS 
nude mice. Homozygous (nu/nu) C57BL/6 nude mice, Balb/c (nu/nu) mice, and 
littermate heterozygous (nu/÷) C57BL/6 and Balb/c mice were injected with S. 
typhimurium LPS (50 #g on day 0, 25 #g on days 7 and 14). As a control, similar 
groups of mice were injected with sterile saline. The mean values of SS  [3H ]DNA 
binding capacity obtained on serum  samples  collected on days 13  and  28  are 
shown in Table  II.  LPS  induced a  significant anti-DNA response  in  C57BL/6 
nude mice and this response was similar to the anti-DNA response induced by 
LPS in C57BL/6 heterozygous mice. Such anti-DNA response was not observed 
in Balb/c nude mice, while a significant increase in DNA-binding capacity was 
observed in heterozygous (nu/+) Balb/c mice after the injection of LPS. 
TABLE I 
Comparative Studies of the Anti-DNA Response after LPS or mBSA-DNA 
Mice strains* 
% SS [SH]DNA ppt ±1 SD$ 
LPS§  mBSA-DNAIr 
NZB ×  NZW  29.8 ±  3.0  41.0 ±  2.1 
C57BL/6  23.0 ±  7.0  22.8 ±  5.0 
C3H  16.5 ±  4.9  9.4 -~ 2.4 
Balb/c  13.9  ± 4.4  12.8  ±  5.6 
NZW  13.5  ±  2.3  20.4  ± 2.8 
DBA/2  11.1  ±  2.5  8.5 ±  3.9 
* 6-wk old female mice (5-8 in each grou). 
$ DNA-binding test performed on day 28  with 0.2  ttg SS  [3H]DNA and 0.1  ml of mouse serum 
diluted  1;I0. 
§ 50 tLg of S. typhimurium was injected on day 0,  25 ttg on days 7 and  14. 
I[ 75 t~g of mBSA-DNA complex was injected in IFA on days 0,  7,  and  14. 
TABLE II 
Anti-DNA Antibody Response to Injections of LPS in Nude Mice 
% SS [SH]DNA ppt ±1 SD* 
Genotype  Group  C57BL/65  Balb/c§ 
D13  D28  D13  D28 
nu/nu  LPSI[  13.0  ±  2.9  18.0  ±  2.0  9.8 ~  1.7  8.4 == 3.4 
nu/nu  Saline¶  9.9 ±  4.0  11.9 ±  1.0  9.2 ±  2.3  8.0 ±  2.0 
nu/+  LPS[]  16.5  ±  2.4  19.1  ±  2.3  9.4 ±  1.1  13.9  ±  4.4 
nu/+  Saline"  13.0  ±  2.9  11.9  ±  3.3  6.5 ±  0.7  5.3 ±  1.0 
* DNA-binding test performed with 0.2 pg SS [~H] DNA and 0.1 ml of mouse serum diluted 1:10. 
8-wk old C57BL/6 male mice (five in each group). 
§ 8-wk old Balb/c female mice (seven in each group). 
IJ 50 ttg of S.  typhimurium  LPS was injected  on day 0,  25 ttg on days 7 and  14  (in 0.2 ml sterile 
saline. 
¶ 0.2 ml sterile saline on days 0,  7,  and  14. GILBERT J.  FOURNIE,  PAUL H.  LAMBERT,  PETER  A.  MIESCHER  1195 
Role of the Doses and of the Nature of the LPS Preparations.  The induction 
of anti-DNA antibodies by injections of LPS was studied in relation to the doses 
of LPS injected. Four groups of C57BL/6 female mice were injected with different 
doses of S.  typhimurium  LPS ranging from a total dose of 20 pg-800 #g/mouse. 
One other group was immunized with mBSA-DNA complexes. It can be seen in 
Fig. 3 that the anti-DNA response induced by injections of LPS was related to the 
amount of LPS injected. At high doses of LPS, the titer of anti-DNA antibodies 
measured  on  day  28  was  higher than  that  observed after immunization with 
mBSA-DNA complexes. The titers of anti-DNA antibodies induced by LPS of 
various  origin  was  studied  on  10-wk  old  NZB  ×  NZW  females  which  were 
injected intraperitoneally with the same amount (50 pg on day 0, 25 #g on days 7 
and 14) of LPS from S. typhimurium, E. coli 0127:B8 and S. enteritidis. All the 
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FIG.  3.  Anti-DNA antibody response of 6-wE old C57BL/6  female mice after injections of 
various doses of S. typhimurium  LPS ([:3) or after immunization with mBSA-DNA complexes 
(75 #g DNA) (O). Groups of seven mice were injected intraperitoneally on days 0, 7, and i4. 
Titers  of  anti-DNA  antibodies  are  expressed  as  the  mean  percentage  of  SS  [~H]DNA 
precipitated obtained in each group. 
LPS tested were able to induce an anti-DNA response,  but the kinetics of this 
response were dependent on the origin of the LPS injected. Indeed, there was no 
significant response induced by S. enteritidis LPS until day 45 (Table III). 
To better define the  active part  of the  molecule of LPS,  LPS  preparations 
obtained from mutant bacteria and lipid A fraction extracted from E. coli were 
tested for their ability to induce anti-DNA antibodies in C57BL/6 mice. Groups 
of 8-wk old mice were injected with the same amount (50 pg on day 0, 25 tLg on 
days 7 and  14) of LPS from E. coli 0111:B4, or from the mutant strains E. coli 
0111:B4, J5 and S. minnesota Re 595, or of lipid A extracted from E. coli 0111:B4. 
As a control, a group of mice was injected with saline alone. The individual titers 
of anti-DNA  antibodies  measured on day 13 are shown in Fig.  4.  All the LPS 
preparations injected induced a significant increase in the DNA-binding capac- 
ity.  The  highest  response  was  obtained  with  mutants  with  a  relatively high 
content of lipid A (Re 595 LPS) and with purified lipid A. A lower response was 
observed with a  more complete molecule of LPS (J5 LPS), which,  on a  weight 
basis, contains a lower amount of lipid A. The lowest response was observed with 
the LPS  preparation which,  on a  weight basis,  contains the lowest amount of 
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Characteristics of Anti-DNA Antibodies Induced by LPS.  The specificity of 
anti-DNA  antibodies  induced  by LPS was studied  by using SS  [SH]DNA and 
purified  DS  [SH]DNA. As shown in Table IV,  sera from mice injected with S. 
typhimurium  LPS  had  a  DNA-binding  capacity  directed  mainly  against  SS 
DNA.  However,  a  significant  increase  of DS  DNA-binding  capacity  was  also 
TABLE  III 
Effect of LPS from Various Sources on Anti-DNA Antibody Production in NZB × NZW 
Mice 
Group* 
% SS  [3H]DNA ppt ±1 SD$ 
D21  D28  D45 
S. typhimurium LPS§  26.5 ±  3.9  29.6 ±  4.9  32.9 ±  4.2 
E. coli0127:B8LPS§  22.2 ±  6.2  26.9 ±  8.4  36.1 ±  4.9 
S. enteritidis  LPS§  14.6 ±  5.1  20.4 ±  4.2  29.6 ±  5.2 
Salinell  12.5 ±  4.8  17.7 ±  2.7  18.0 ±  1.4 
* 10-wk old NZB  x  NZW Ft hybrid female mice (5  7  mice in each group). 
DNA-binding test performed with 0.2 ttg SS  [3H]DNA and 0.1 ml mouse serum diluted  1:10. 
§ 50 ttg of LPS was injected on day 0,  25 t~g on days 7 and 14 (in 0.2 ml sterile saline). 
II 0.2 ml sterile saline on days 0,  7,  and 14. 
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FIG.  4.  Induction of anti-DNA antibodies in 6-wk old C57BL/6 female mice by injections of 
various  LPS  preparations.  Five  mice  in  each  group  were  injected  with  50  ttg  of the  LPS 
preparation on day 0, 25 #g on days 7 and 14. Individual anti-DNA antibody levels obtained on 
day 13 are represented by the percentage of SS  [SH]DNA precipitated. 
observed. In mice injected with lipid A, the DNA-binding capacity was high, not 
only  for  SS  [3H]DNA,  but  also for  DS  [3H]DNA.  The  kinetics  of antibodies 
directed  against  DS  DNA  were  similar  to  the  kinetics  of antibodies  directed 
against  SS  DNA.  The  specificity  of these  anti-DNA  antibodies  was  further 
confirmed by inhibition  studies with cold DS DNA and cold SS DNA from calf 
thymus.  With  DS  [3H]DNA  as  antigen  (0.2  ug),  the  binding  capacity  of 
anti-DNA  antibodies  induced  by  lipid  A  was  strongly  inhibited  by  prior GILBERT J.  FOURNIE,  PAUL H.  LAMBERT,  PETER  A.  MIESCHER  1197 
incubation with 2.5  #g of either DS  DNA or SS  DNA.  With SS  [3H]DNA  as 
antigen (0.2 ttg), the binding capacity of the same antibodies was not inhibited at 
all by prior incubation with 2.5 ttg of DS DNA, but was strongly inhibited by the 
addition of 2.5  #g of SS  DNA.  These studies indicate that the sera from mice 
injected with lipid A did contain antibodies with two types of specificity: some 
reacting only with the antigenic determinants of SS DNA and some reacting with 
antigenic determinants common to SS DNA and to DS DNA. 
The anti-DNA antibodies induced by LPS were further defined by gel filtration 
on Sephadex G 200. By using pools of sera collected on day 28 from C57BL/6 mice 
TABLE IV 
Specificity of Anti-DNA Antibodies Induced by LPS and Lipid A 
Group* 
% [3H]DNA ppt ±1 SD$ 
DS [~H]DNA  SS(3H]DNA 
LPS§  9.6 ±  2.4  23.1 ±  2.8 
Lipid All  22.1 ±  3.4  37.9 ±  6.2 
Saline¶  4.4 ±  1.4  7.1 -  0.9 
* 6-wk old C57 BL/6 females (5-7 in each group). 
SMeasured  on  day  13  by  using 0.2  ug  of  [3H]DNA  and  0.1  ml  mouse 
serum  diluted 1:10. 
§ 50 ttg of S.  typhimurium  was injected  on day 0,  25 ttg on day 7. 
II 50 #g of lipid  A  extracted from E. coli 0111:B4  was injected  on day 0, 
25 ttg on day 7. 
¶ 0.2 ml sterile saline on days 0  and 7. 
injected with S. typhimurium LPS, a  [125I]DNA-binding  activity was detected in 
both the first and second peaks eluted from the Sephadex G 200 column. From 
quantitative estimation, it was found that the amount of antibody contained in 
the  first  peak  was  higher  than  that  of  the  second  peak.  When  anti-DNA 
antibodies  were  induced  in  mice  of  the  same  strain  by  immunization with 
mBSA-DNA complexes and then fractionated in a similar way, a larger part of 
the  DNA-binding  activity  was  found  in  the  second  peak  of  elution.  The 
characteristics of anti-DNA antibodies induced in poor responder mice may be 
different. Indeed, pools of sera collected on day 28 from DBA/2 mice injected with 
either LPS  or  with  mBSA-DNA complexes were shown to  contain anti-DNA 
antibodies  which  were  eluted  only  in  the  first  peak  of the  Sephadex  G  200 
column. 
Release  of DNA  in  Circulating  Blood  after Injections  of LPS.  Since  it  is 
known that  bacterial LPS  can  lead  in vivo to tissue  destruction and cellular 
disruption, the possibility that endogenous nuclear material might be released 
and play a role in the production of anti-DNA antibodies was investigated. For 
this purpose,  10 C57BL/6 mice were injected intraperitoneally with 300 ttg of S. 
typhimurium LPS and bled at various times after injection. Sera were collected 1198  DNA  RELEASE  AND  ANTI-DNA  ANTIBODIES  INDUCED  BY  LPS 
very carefully to prevent any cell destruction,  and the amount of DNA present in 
serum  was  evaluated  by  inhibition  of  DNA-binding  test.  A  very  significant 
inhibition  of  the  binding  of  SS  [3H]DNA  and  of  [I~SI]DNA  by  anti-DNA 
antibodies from the lupus patient serum used was observed in presence of serum 
samples  collected  between  4  and  20  h  after  the  injection  of LPS.  By  using  a 
standard  inhibition  curve,  the  amount  of circulating  DNA was estimated  (Fig. 
5).  With  reference  to  calf thymus  DNA,  a  peak  of approximately 40  #g/ml  of 
DNA was found  in  circulating  blood  after  11  h.  This experiment  was repeated 
several  times  and  the  highest  concentration  of  DNA  in  serum  was  usually 
detected 8-10 h  after the injection of LPS. Prior treatment of the tested sera with 
DNase  resulted  in  an  almost  complete  disappearance  from  the  sera  of  the 
material responsible for the inhibition of the DNA binding (Fig. 5). The presence 
of a significant amount of DNA in the preparation of LPS injected was excluded 
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FIG. 5.  DNA released in circulating blood after the injection of 300 tLg of S. typhimurium LPS 
in  10 C57BL/6 mice. Pools of sera were collected at various times  after this  injection and 
assayed  for DNA content  by inhibition  of  [~H]DNA binding.  Closed circles represent  the 
amount  of circulating  DNA. Open  circles represent  the  amount  of circulating  DNA still 
detectable  after pretreatment of the serum samples with DNase. 
since  LPS  did  not  inhibit  the  binding  of  SS  [~H]DNA  by  the  anti-DNA 
antibodies  from the  lupus  patient  serum.  In  similar experiments,  it was found 
that E. coli 0111:B4 LPS and lipid A could induce a release of DNA in circulating 
blood  like  S.  typhimurium  LPS.  Moreover,  a  second  injection  of LPS,  7  days 
after the first injection,  again induced a similar release of DNA. In another group 
of  experiments,  other  strains  of  mice  were  studied.  Circulating  DNA  was 
detected  in  serum  after  the  injection  of LPS  in  all the  strains  tested:  NZB  × 
NZW F~ hybrids,  Balb/c,  homozygous nude Balb/c,  and  OF1 outbred mice. 
Characteristics  of the DNA  Released after Injection  of LPS.  The  physico- 
chemical nature of DNA circulating in mouse blood 7 h  after the injection of 300 
ttg  of  S.  typhimurium  LPS  was  studied  by  chromatography  on  methylated 
albumin  kieselguhr  column.  Preliminary  studies  using  [aH]DNA  in  its  native 
from and  after heat  denaturation  indicated  that  in our experimental conditions 
native DNA was mostly eluted  in 0.5  M  NaC1,  while heat-denatured  DNA was 
eluted  in  1 M  NaC1,  1.5  M  NH,OH  phosphate buffer (Fig.  6).  DNA-containing 
serum, obtained after injections of LPS, was processed in similar conditions and 
the fractions eluted  at various salt concentrations were checked after dialysis in GILBERT  J.  FOURNII~,  PAUL H.  LAMBERT,  PETER A.  MIESCHER  1199 
borate buffer for their content of DNA by inhibition of [SH]DNA  or  [12SIJDNA- 
binding test. The amount of DNA was estimated with reference to a standard 
inhibition curve performed with calf thymus DNA. As shown in Fig. 6, there is a 
small amount of DNA present  in normal mouse serum which is  eluted at the 
molarity corresponding to the elution of SS DNA. Serum from mice injected with 
LPS contained a much greater amount of DNA, which is eluted in two peaks. The 
smaller peak is eluted at the molarity corresponding to the elution of DS DNA 
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Fro.  6.  Physicochemical characteristics of circulating DNA on methylated albumin kiesel- 
guhr column. The upper part of the graph represents the pattern of elution of DNA detected 
either in normal mouse serum or in serum from mice injected with LPS. The vertical bars 
correspond to the concentration of DNA in each fraction studied. The optical density of these 
fractions is  indicated  by  the continuous lines. The lower part  of the graph represents the 
pattern of elution obtained with native [SH]DNA and with heat-denatured [SH ]DNA. 
and the larger one at the molarity corresponding to the elution of SS DNA. Prior 
treatment of the fraction samples by DNase prevented their inhibitory effect on 
[3H]DNA-binding by anti-DNA antibodies. 
The  DNA  released  in  circulating  blood  after  injection  of LPS  was  further 
characterized by immunochemical analysis. The inhibitory activity of a  serum 
pool from mice injected with LPS was compared to that of cold SS DNA and cold 
DS DNA by using as antibody a lupus patient serum and as antigen either SS 
[SH]DNA  or  DS  [3H]DNA.  This  anti-DNA  antibody  was  selected  for  its 
specificity which allowed for a  differentiation between SS DNA and DS  DNA 
(with DS  [SH ]DNA as antigen) and for an estimation of the total content of DNA 
in  serum  (with SS  [3H]DNA  as  antigen).  Indeed, this  antibody had a  higher 
avidity for DS DNA than for SS DNA. The ratio of the absolute amounts of DNA 1200  DNA  RELEASE  AND  ANTI-DNA ANTIBODIES  INDUCED BY  LPS 
bound in presence of 0.225 pg or 2.7 tLg of DNA was 0.15 for SS  [3H]DNA and 0.42 
for DS  [3H]DNA. With this particular  anti-DNA antibody,  in the  conditions  of 
the experiment, the addition of cold SS DNA inhibited equally the binding of SS 
[3H]DNA and ofDS  [aH]DNA (Table V). On the other hand, the addition of cold 
DS  DNA inhibited  more strongly the  binding of DS  [SH]DNA than  that  of SS 
[3H]DNA.  When  the  inhibitory  activity of serum from mice injected  with LPS 
was evaluated,  it was found that the  pattern of inhibition  was largely related to 
that obtained with cold SS DNA. Indeed, for this particular pool of mouse serum, 
the amount of DNA estimated by inhibition of the binding of SS  [SH ]DNA would 
be approximately equivalent to 25 gg/ml of either cold DS DNA or cold SS DNA. 
In contrast,  the values obtained by inhibition  of DS  [3H]DNA binding would be 
TABLE V 
Immunochemical Study of DNA Released a[ter Injection of LPS 
Added serum 
% pH]DNA ppt* 
SS  [3H]DNA  DS [~H]DNA 
NMS$  39  41 
LPS-MS§  29  26 
NMS + SS DNAII (25 #g/ml)  31  28 
NMS + DS DNAII (25 #g/ml)  29  17 
* 100 #l  of anti-DNA systemic lupus erythematosus serum  1:50 added to 
I00 ttl of tested serum lk:!10 then to 0.2 ;~g  [3H]DNA in a  direct-binding 
test. 
$ Pool of sera from 6-wk old normal C57BL/6 female mice. 
§ Pool of sera from 6-wk old C57BL/6 female mice collected 8 h after an 
intraperitoneal  injection of 200 ttg of S. typhimurium  LPS. 
I[ 10 ;,1 of calf thymus DNA (25 pg/ml) in 100 pl of normal mouse serum 
diluted  1:10. 
approximately equivalent to either 25 ttg/ml of cold SS DNA or to 5 ~g/ml of cold 
DS  DNA.  Therefore,  it  is  likely  that  most  of  this  circulating  DNA  reacts 
immunochemically in a  similar way to SS DNA. 
Discussion 
The  present  data  are  concerned  with  two  different  effects  of  bacterial  LPS 
observed in mice: first, a  release of DNA in  circulating  blood,  and  secondly,  an 
induction of anti-DNA antibodies. The relationship between these two phenom- 
ena and their pathogenic significance will be discussed. 
In  the  early  phase  after  injection  of  LPS  into  mice,  a  release  of DNA  in 
circulating  blood was demonstrated  in several experiments.  The  appearance of 
DNA  in  the  circulating  blood  a  few  hours  after  the  injection  of LPS  is  not  a 
phenomenon  restricted  to  some  particular  mice,  since  it  was  found  in  several 
inbred  and  outbred  strains  of  mice.  It  should  be  pointed  out  that  the  DNA GILBERT J. FOURNIE, PAUL H. LAMBERT,  PETER A. MIESCHER  1201 
estimations  were  done  with  reference  to  DNA  from  a  different  species  and 
therefore the  estimations  should  be considered  as approximate and  likely to be 
influenced by the molecular size and by the nature of released DNA, rather than 
absolute  quantitation.  The  physico.chemical  and  immunochemical  data  sug- 
gested that  most of the  DNA circulating after tile  injection of LPS had several 
characteristics  of SS  DNA.  Indeed,  the  elution  profile of this  released DNA on 
methylated albumin kieselguhr columns is similar to that of a mixture containing 
a  small  amount of DS  DNA and  a  large amount of SS  DNA.  It is also possible 
that  released  DS  DNA  would  acquire  a  high  affinity  for methylated  albumin 
kieselguhr, through the uncoiling of one part of the DNA molecule or through the 
binding  to  cellular  components  or  to  serum  proteins.  The  immunochemical 
analysis  also  indicates  that  the  specificity  of  the  released  DNA  corresponds 
largely to that of SS DNA. The antibody used in these inhibition studies reacted 
with  antigenic  determinants  present  in  both SS  DNA and  DS  DNA but  had  a 
higher avidity for DS DNA. Our data did not exclude the presence of DS DNA in 
sera  from mice  injected  with  LPS,  but  suggested  strongly  that  DNA with  the 
characteristics of SS DNA was responsible for most of the inhibition of the DNA 
binding by the anti-DNA antibodies  used in these experiments. 
The  mechanism  responsible  for  the  release  of DNA  into  circulating  blood  after  the 
injection of LPS has not been elucidated, but several hypotheses may be considered. First, 
it is well known that bacterial endotoxins have a cytotoxic effect on nucleated cells in vitro 
(32, 33).  A similar effect may lead to a release of endogenous nuclear material from cells 
disrupted "in vivo." Secondly, severe generalized reactions may be induced in the host by 
the  injection  of LPS.  When  injected  in  sufficient  amounts,  endotoxins  may  cause  a 
hemorrhagic  shock,  and  smaller  doses  would  cause  fever,  leukopenia,  hemorrhagic 
necrosis, and a wide variety of circulatory disturbances (32, 34). These manifestations lead 
indirectly  to  disseminated  cell  disruptions  which  may  also  account  for  a  release  of 
endogenous nuclear material. Thirdly,  it was shown that during endotoxin hemorrhagic 
shock, there is an absorption of bacterial material from the bowel (35), which might lead 
to the appearance of exogenous nuclear material in serum. Apart from the questionable 
origin of DNA released in serum, the persistence of a relatively high concentration of DNA 
in the circulating blood during a few hours can only be explained either by a continuous 
and intense release of DNA during this period or by a particular form of this DNA, since it 
is known that the clearance of circulating DNA in mice is very fast, with a half-life of a few 
minutes (36). 
It  was  surprising  to  see  that  the  injection  of LPS  alone  induced  an  immune 
response to DNA. In the first experiment, young NZB  ×  NZW F1 hybrid mice, 
which would later naturally develop such anti-DNA antibodies,  were used,  and 
therefore the effect of LPS might be interpreted as an enhancement of a natural 
phenomenon.  However,  it  was  clear  that  the  injections  of LPS  were  inducing 
similar anti-DNA antibodies  in other  strains  of mice such  as C57BL/6 or C3H, 
which do not spontaneously develop a  significant  level of anti-DNA antibodies. 
This induction of anti-DNA antibodies by LPS was quite efficient since C57BL/6 
mice developed even higher titers  of anti-DNA  antibodies  after injections  of a 
high  dose  of LPS  than  after  immunization  with  mBSA-DNA  complexes.  The 
increase in  [SH ]DNA binding induced  by LPS is due to the presence in serum of 1202  DNA RELEASE  AND  ANTI-DNA ANTIBODIES INDUCED BY  LPS 
antibodies  with  two  types  of  specificity.  Most  of  them  react  with  antigenic 
determinants  present  only  on  SS  DNA,  but  it  is  of particular  importance  to 
note  that  antibodies  reacting  with  DS  DNA  appeared  in  the  serum  of  mice 
(C57BL/6) injected with LPS or with lipid A. This observation is of interest since 
it  has  been  frequently  stated  that  anti-DS  DNA  antibodies  appear  only  in 
systemic lupus erythematosus or in the natural disease ofNZB  ×  NZW F1 hybrid 
mice (37, 38). It should be noted that the DS  [3H ]DNA used in these studies has 
been  previously purified  on  a  methylated  albumin  kieselguhr  column  and  was 
shown  to  contain  less  than  1%  of  [SH]DNA  reacting  with  anti-SS  DNA 
antibodies. Moreover, the specificity of these anti-DS DNA antibodies has been 
confirmed by inhibition experiments. The elution profile of anti-DNA antibodies 
induced by LPS on Sephadex G  200 suggests that both 19S and 7S antibodies are 
present  in the  sera obtained  after 4 wk. In some strains of mice such as DBA/2 
mice,  most of the  anti-DNA  antibody  activity found  after injections of LPS  is 
present  in  the  19S  peak.  Similar  patterns  have  been  previously  described  in 
DBA/2 mice immunized with mBSA-DNA complexes (39). The active part of the 
LPS  molecule  in the induction  of anti-DNA antibodies  seems to be common to 
various gram-negative bacterial  endotoxins,  since  similar effects were observed 
with LPS extracted from S.  typhimurium,  S. enteritidis, or E. coli. It appears to 
be  the  phospholipid  fraction  containing  lipid  A  since  there  is  a  positive 
correlation  between  the  titers  of  anti-DNA  antibodies  induced  in  mice  by 
injections  of  equivalent  amounts  of  lipid  A  or  of  LPS  from  various  mutant 
bacteria  and  the  absolute  concentration  of  lipid  A  per  mole  in  these  LPS 
preparations.  Lipid A  was also shown to be responsible for the ability of LPS to 
induce lymphocyte mitogenesis and to act as an adjuvant on antibody formation 
(24). 
Several  mechanisms  can  be  proposed  in  order  to  explain  the  induction  of anti-DNA 
antibodies by LPS. The effect of LPS on the immune system should be considered as well 
as the release of DNA which has been demonstrated in circulating blood. In addition,  a 
genetic background probably modulates the intensity of the anti-DNA response induced 
by LPS. The studies performed in several inbred strains of mice show that some strains 
developed  a  good  anti-DNA  response  after  injections  of LPS,  while  others  are  poor 
responders. 
The  pattern  of the  anti-DNA  response  induced  by LPS  corresponds  largely  to  the 
pattern of the anti-DNA response induced by immunization with mBSA-DNA in the same 
strains of mice. Since the immune response to DNA has been shown to be under genetic 
control (11),  it is likely that there is a similar control for the anti-DNA response induced 
by LPS.  However, it should  be pointed out that in C3H mice, which respond poorly to 
mBSA-DNA, a better response could be obtained after injections of LPS, indicating that 
other control mechanisms may be involved in this response. On the other hand, there is no 
correlation of the intensity of the anti-DNA response induced by LPS with the level of 
antibody  directed  against  the  antigenic  part  of the  PLS  molecule,  nor  with  the  H-2 
histocompatibility locus, since NZB, Balb/c, and DBA/2 mice have the same H-2  ~ locus. 
The effects of LPS on the immune system may proceed through several channels. First, 
high doses of LPS may depress the host resistance to viral or bacterial infections (40), and 
therefore  favor the  development  of a  natural  infection  eventually  responsible  for  the 
triggering of the production of anti-DNA antibodies. However, this effect on LPS on host 
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resistance to infections (41, 42). The induction of anti-DNA antibodies by LPS does not 
depend  on a  similar  dose  effect relationship  since  the  titer  of anti-DNA antibodies  is 
directly related to the amount of LPS injected.  Secondly, it is well known that LPS is a 
potent mitogen for B lymphocytes (19, 20) and it has been shown, in vitro, that LPS could 
induce  a  polyclonal  stimulation  of such  lymphocytes  and  lead  to  the  appearance  of 
plaque-forming cells reacting with various antigens (43). A similar polyclonal effect might 
be expected in vivo, but it has not been reported as yet. Moreover, in our experiments, the 
injection of LPS in NZB × NZW F1 hybrid mice is followed by a production of anti-DNA 
antibodies,  but  not  of autoantibodies  reacting with  autologous red  cells.  Thirdly,  the 
nonspecific adjuvant effect of LPS does not seem to play a  major role  in the anti-DNA 
response since LPS did not enhance the immune response to mBSA-DNA. Furthermore, 
the  injection of IFA alone  in  NZB  ×  NZW mice only induced  a  late,  very slight,  and 
transient  response to DNA. Fourthly, LPS was shown to favor the immune response to 
thymus-dependent antigens in animals deprived of T  lymphocytes (44). This effect may 
be of particular importance in the immune response to autologous antigens. An immune 
response to human IgG globulins can be elicited by simultaneous injection of this antigen 
and of LPS in mice previously rendered unresponsive to this antigen, but characterized by 
a state of T-cell tolerance or of B-cell responsiveness (21). Moreover, as shown by Louis et 
al.  (45), LPS  interferes with the induction of tolerance by injection of soluble IgG and 
converts it to an immunization process. Since it has been shown that there is a release  of 
DNA into circulating blood which occurs a few hours after the injection of LPS, one may 
wonder whether the simultaneous action of LPS and of soluble DNA on B lymphocytes 
would not lead to a state of immunity comparable to that obtained in the IgG system. The 
role of a stimulation of B lymphocytes in the induction of anti-DNA antibodies by LPS is 
further suggested by the fact that the injection of LPS into athymic homozygous nude 
C57BL/6 mice results in a production of anti-DNA antibodies similar to that observed in 
heterozygous (nu/+) C57BL/6 mice. However, since it is known that a few T lymphocytes 
may persist in nude mice (46, 47), one cannot exclude, as suggested by recent observation 
{48,  49),  that  the  effect  of  LPS  on  anti-DNA  antibody  production  also  involves 
thymus-derived lymphocytes. Fifthly, one should  also  consider the  possibility that  the 
DNA which  is  released  in  circulating  blood  after  the  injection  of LPS  would be  in  a 
particularly good immunogenic form. 
The  present  observation  may have  a  double  pathogenic significance. The fact 
that LPS can induce anti-DNA antibodies in mice suggests that these phenom- 
ena may play a  role in the triggering or in the enhancement of the production of 
anti-DNA antibodies occurring occasionally during infections with gram-negative 
bacteria. Analogous mechanisms might be involved in the induction of anti-DNA 
antibodies  during  some  viral  infections  and,  perhaps,  in  the  development  or 
exacerbation  of systemic  lupus  erythematosus.  A  chronic  release  of bacterial 
endotoxins in vivo might also lead to a  chronic release of DNA in the presence of 
anti-DNA  antibodies.  Therefore,  DNA-anti-DNA complexes  might  be  formed 
and  prepare  the  way  for  the  development  of  a  lupus  type  immune  complex 
disease. 
Summary 
The  present  data  demonstrate  the  induction of antisingle-stranded  (SS)  DNA 
and  antidouble-stranded  DNA antibodies  in  various strains  of mice,  including 
athymic C57BL/6 nude mice,  after the injection of bacterial  lipopolysaccharide 1204  DNA  RELEASE  AND  ANTI-DNA  ANTIBODIES  INDUCED  BY  LPS 
(LPS).  This  anti-DNA  response  is  dose  dependent  and  varies  quantitatively 
according  to  the  strain  of  the  injected  mice.  It  is  not  correlated  to  the  H-2 
histocompatibility locus nor to the immune response to LPS. The lipid A fraction 
appears  to  be the  active part of the  LPS  molecule for this  particular  effect. In 
addition,  it was found that DNA is released in circulating blood a few hours after 
the  injection  of  LPS.  Most  of  the  DNA  released  has  physicochemical  and 
immunochemical characteristics  of SS DNA. Therefore, the anti-DNA response 
induced  by  injections  of  LPS  may  be  the  result  of  a  release  of  DNA  in  a 
particularly immunogenic form at a time when the immune system, in particular 
the  B  lymphocytes,  is  rendered  capable  by  LPS  of  developing  an  immune 
response  to  such  a  soluble  antigen.  These  effects  of LPS  may  account  for the 
triggering  or  the  exacerbation  of ante-DNA  antibodies  during  infections  with 
gram-negative  bacteria,  and  a  similar  mechanism  may  be  involved  in  the 
pathogenesis of systemic lupus erythematosus. 
The authors wish to thank Miss Edith MSdder and Mr. Guy Brighouse for their excellent technical 
assistance. 
Received for publication 8 July 1974. 
References 
1.  Cepellini,  R.,  E.  Polli,  and  F.  A.  Celada.  1957. DNA-reacting factor in serum of a 
patient with lupus erythematosus diffusus. Proc. Soc. Exp. Biol. Med. 96:572. 
2.  Holman H.  R.,  and  H.  G.  Kunkel.  1957. Affinity between the  lupus erythematosus 
serum factor and cell nuclei and nucleo protein. Science (Wash."D.  C.).  126:162. 
3.  Miescher, P., and R. Straessle. 1957. New serological methods for the detection of the 
LE factor.  Vox Sang.  2:145. 
4.  Seligmann,  M.  1958. Etudes immunologiques sur le lupus erythemateux diss~min~. 
Rev. Fr. Etud.  Clin. Biol. 3:358. 
5.  Norins,  L.  C.,  and  M.  C.  Holmes.  1964. Antinuclear  factor in  mice. J.  Immunol. 
93:148. 
6.  Lambert,  P.  H.,  and  F.  J.  Dixon.  1968. Pathogenesis  of the  glomerulonephritis  of 
NZB/W mice. J. Exp. Med.  127:507. 
7.  Burner,  F.  M., and M. C. Holmes. 1965. The natural history of the NZB  x  NZW F1 
hybrid mouse: a laboratory model of systemic lupus erythematosus. Australas. Ann. 
Med.  14:185. 
8.  Howie, J. B.,  and B. J. Helyer. 1968. The immunology and pathology of NZB mice. 
Adv. Immunol.  9:215. 
9.  Koffler,  D.,  V.  Agnello,  R.  Thoburn,  and  H.  G.  Kunkel.  1971. Systemic  lupus 
erythematosus:  prototype  of  immune  complex  nephritis  in  man.  J.  Exp.  Med. 
134:169  s. 
10.  Borel, Y.,  R. M. Lewis, and B. D. Stollar. 1973. Prevention of murine lupus nephritis 
by carrier-dependent induction of immunologic tolerance to denatured DNA. Science 
(Wash. D. C.).  182:76. 
11.  Lambert,'P. H.,  and F. J.  Dixon.  1970. Genesis of antinuclear antibody in NZB/W 
mice: role of genetic factors and of viral infections.  Clin. Exp. Irnmunol.  6:829. 
12.  Stollar,  B.  D.,  S.  Fuchs,  and  E.  Mozes.  1973. Immune response of mice to nucleic 
acids: strain-dependent differences in magnitude and class of antibody production. J. 
Immunol.  111:121. GILBERT  J.  FOURNII~,  PAUL  H.  LAMBERT,  PETER  A.  MIESCHER  1205 
13.  Miescher, P. A., and F. Paronetto. 1969. Systemic lupus erythematosus. In Textbook 
of Immunopathology. Miescher and Muller-Eberhard, editors. Grune & Stratton Inc., 
New York. 56:675. 
14.  Mellors,  R.  C.,  T.  Aoki,  and  R.  J.  Huebner.  1968. Further  implication  of murine 
leukemia-like virus in the disorders of NZB mice. J. Exp. Med.129:1045. 
15.  Tonietti, G., M. B. A. Oldstone, and F. J. Dixon. 1970. The effect of induced chronic 
viral infections on the  immunologic diseases of New  Zealand  mice. J.  Exp.  Med. 
132:89. 
16.  Christian,  C. L., A. R. Desimone, and J. L. Arbuzzo. 1965. Anti-DNA antibodies in 
hyperimmunized rabbit.s.J. Exp. Med.  121:309. 
17.  Grabar,  P.,  S.  Avrameas,  B.  Taudou,  and  J.  C.  Salomon.  1968. Formation  and 
isolation of antibodies specific for nucleotides. In Nucleic Acids in Immunology. O. J. 
Plescia and W. Braun, editors. Springer-Verlag, Inc. New York. 79. 
18.  Johnson,  A.  G.,  S.  Gaines,  and  M.  Landy.  1956. Studies  on  the  O  antigen  of 
Salmonella typhosa. V. Enhancement of antibody response to protein antigens by the 
purified lipopolysaccharide. J. Exp. Med.  103:225. 
19.  Gery,  I.,  J.  Kruger,  and  S.  Z.  Spiesel.  1972. Stimulation  of  B  lymphocytes  by 
endotoxin reaction of thymus deprived mice and kariotypic analysis of dividing cells 
in mice bearing T6T6 thymus grafts. J. Immunol.  108:1088. 
20.  Anderson, J., G. MSller, and O. SjSberg. 1972, Selective induction of DNA synthesis 
in T  and B lymphocytes. Cell.  Immunol.  4:381. 
21.  Chiller,  J.  M.,  and  W.  O.  Weigle.  1973. Termination  of  tolerance  to  human 
gammaglobulin in mice by antigen and bacterial lipopolysaccharide (endotoxin). J. 
Exp. Med.  137:740. 
22.  Weigle, W.  O.  1971. Recent observations and concepts in immunological unrespon- 
siveness and autoimmunity. Clin. Exp. Immunol.  9:437. 
23.  Allison, A.  C.  1973. Mechanisms of tolerance and autoimmunity. Ann. Rheum. Dis. 
32:283. 
24.  Chiller, J. M., B. J. Skidmore, D. C. Morrison, and W. O. Weigle. 1973. Relationship 
of the structure  of bacterial  lipopolysaccharides to its function in  mitogenesis and 
adjuvancity. Proc. Natl. Acad. Sci.  U.S.A. 70:2129. 
25.  Sueoka, N.,  and T. Y. Cheng.  1967. Fractionation  of DNA on methylated albumin 
column. Methods Enzymol.  12A:562. 
26.  Tan, E. M., and P. G. Natali.  1970. Comparative study of antibodies to native and 
denatured DNA. J. Immunol.  104:902. 
27.  Wold,  R. T., F.  E. Young,  E.  M. Tan, and R. S.  Farr.  1968. Deoxyribonucleic acid 
antibody:  a  method  to  detect  its  primary interaction  with  deoxyribonucleic acid. 
Science (Wash. D. C.).  161:806. 
28.  Commerford, S. L. 1971. Iodination of nucleic acids in vitro. Biochemistry.  10:1993. 
29.  Marmur,  J.  1961.  A  procedure  for  the  isolation  of  deoxyribonucleic  acid  from 
microorganism. J. Mol. Biol. 3:208. 
30.  Rudbach,  J.  A.  1971. Molecular  immunogenicity  of  bacterial  lipopolysaccharide 
antigens:  establishing a quantitative system. J. Immunol.  106:993. 
31.  East, J., M. A. B. de Sousa, and D. M. V. Parrot.  1965. Immunopathology of NZB 
mice. Transplantation  {Baltimore). 3:711. 
32.  Milner, K. C., J. A. Rudbach, and E. Ribi. 1971. General characteristics. In Microbial 
Toxins. G. Weinbaum,  S.  Kades, and S. J. Ajl,  editors. Academic Press, Inc., New 
York. 4:6. 
33.  Heilman, D. H., and H. W. Bernton. 1961. The effect ofendotoxin on tissue cultures of 
slpeen of normal and tuberculine-sensitive animals. Am. Rev. Respir. Dis. 84:862. 
34.  Liideritz,  O.,  C.  Galanos,  V.  Lehmann,  M.  Nurminen,  E.  T.  Rietschel,  G.  Rosen- 1206  DNA  RELEASE  AND  ANTI-DNA  ANTIBODIES  INDUCED  BY  LPS 
felder,  M.  Simon, and O. Westphal.  1973. Lipid A: chemical structure and biological 
activity. J. Infect. Dis.  128:S17. 
35.  Fine, J.,  E. D.  Frank,  H. A. Ravin, S.  H. Rutenberg,  and F.  B. Schweinburg. 1959. 
The bacterial [actor in traumatic shock. N. Eng. J. Med. 260:214. 
36.  Chused, T. M.,  A. D. Steinberg, and N. Talal.  1972. The clearance and localization of 
nucleic acids by New Zealand and normal mice.  Clin.  Exp. Immunol.  12:465. 
37.  Hughes,  G.  R.  V.  1971. Significance  of  anti-DNA  antibodies  in  systemic  lupus 
erythematosus. Lancet. 2:861. 
38.  Steinberg, A. D.,  T. Pincus,  and N. Talal.  1969. DNA binding assay for detection of 
anti-DNA antibodies in NZB/NZW F1 mice. J. Immunol.  102:788. 
39.  Stollar,  B.  D.,  S.  Fuchs,  and  E.  Mozes.  1973. Immune response of mice to nucleic 
acids: strain-dependent differences in magnitude and class of antibody production. J. 
Immunol. 3:121. 
40.  Rosen,  F.  S.  1961. The endotoxin of gram negative bacteria and host resistance.  N. 
Engl. J. Med. 264:919. 
41.  Rowley,  D.  1956. Rapidly  induced  changes  in  level  of non-specific  immunity  in 
laboratory animals. Br. J. Exp. Pathol. 37:223. 
42.  Landy, M.  1956. Increase in resistance following administration ot' bacterial lipopoly- 
saccharides. Ann. N.  Y. Acad. Sci. 66:292. 
43.  Anderson,  J.,  O.  SjSberg,  and  G.  Mbller.  1972. Induction of immunoglobulins and 
antibody synthesis in vitro by lipopolysaccharides. Eur. J. Immunol. 2:349. 
44.  MSller,  G.  and  G.  Michael.  1971. Frequency of antigen-sensitive  cells  to  thymus- 
independent antigens. Cell.  Irnmunol. 2:309. 
45.  Louis,  J.  A.,  J.  M.  Chiller,  and  W.  O.  Weigle.  1973. The  ability  of  bacterial 
lipopolysaccharide  to  modulate  the  induction  of  unresponsiveness  to  a  state  of 
immunity. Cellular parameters. J. Exp. Med.  138:1481. 
46.  Lamelin, J. P., B. Lisowska-Bernstein, A. Matter,  J. E. Ryser, and P. Vassali.  1972. 
Mouse  thymus-independent  and  thymus-derived  lymphoid  cells.  J.  Exp.  Med. 
136:984. 
47.  Raft, M.  C.  1973. 0-Bearing lymphocytes in nude mice. Nature (Lond.). 246:350. 
48.  Armending, D.,  and D. H. Katz. 1974. Activation of T and B lymphocytes in vitro. I. 
Regulatory influence of bacterial  lipopolysaccharide (LPS) on specific T cell  helper 
function. J. Exp. Med.  139:24. 
49.  Kagnoff, M. F.,  P. Billings,  and M. Cohn. 1974. Functional characteristics of Peyer's 
patches lymphoid cells.  II.  Lipopolysaccharide is thymus dependent. J. Exp. Med. 
139"407. 